Skip to main content
. 2021 Nov 2;11:21443. doi: 10.1038/s41598-021-01073-0

Figure 4.

Figure 4

A 69-year-old male (case 7) with dry eye disease used latanoprost 0.005% (Xalatan, Pfizer, New York, NY, US, with 0.02% BAK) for one year. He was referred to our clinic with the presumed diagnosis of HSK, and centrally located type II linear pseudodendritic lesions formed by grouped superficial punctate keratitis was found in the left eye (a, b). The viral culture was negative. The topical anti-glaucoma agents were discontinued followed by application of therapeutic soft contact lenses. The main lesion resolved within two weeks (c, d).